Get the Stockscreener App
0.17
4.17%
-0.0074
Syra Health Corp Stock (SYRA) Forecast
The Syra Health Corp (SYRA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.0396, representing a +511.51% increase from the current price of $0.17. The highest analyst price target is $0.9792, and the lowest is $1.10.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SYRA Price Target
Average 4.0607
(+2,289% Upside)
Is Syra Health Corp (SYRA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 63.75 | Neutral |
| STOCH(9,6) | 85.09 | Sell |
| STOCHRSI(14) | 82.32 | Sell |
| MACD(12,26) | 0.00583 | Buy |
| ADX(14) | 25.21 | Buy |
| William %R | -15.38 | Sell |
| CCI(14) | 217.56 | Buy |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.1114
Buy
|
0.1252
Buy
|
| MA20 |
0.0955
Buy
|
0.1117
Buy
|
| MA50 |
0.1311
Buy
|
0.1495
Buy
|
| MA100 |
0.2712
Sell
|
0.2351
Sell
|
| MA200 |
0.2222
Sell
|
0.00
Buy
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, SYRA could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 6 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on SYRA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 63.75 indicates that SYRA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 85.09 indicates that SYRA is oversold. This means that SYRA price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 82.32 indicates that SYRA is oversold. This suggests that SYRA price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.21 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 217.56 indicates that SYRA is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term SYRA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Syra Health Corp financial reports and earnings history, Syra Health Corp (SYRA) stock could reach $14.44 by 2030, $40.40 by 2040 and $61.72 by 2050. See the projected annual prices until 2050 of the Syra Health Corp stock below:
- Syra Health Corp (SYRA) is expected to reach an average price of $27.30 in 2035, with a high prediction of $27.47 and a low estimate of $27.33. This indicates an $15,961% rise from the last recorded price of $0.17.
- Syra Health Corp (SYRA) stock is projected to chart a bullish course in 2040, with an average price target of $38.77, representing an $22,703% surge from its current level. The forecast ranges from a conservative $39.12 to a sky-high $40.40.
- Our analysts predict Syra Health Corp (SYRA) to jump 28,799% by 2045, soaring from $49.25 to an average price of $49.13, potentially reaching $52.02. While $49.25 is the low estimate, the potential upside is significant.
- Syra Health Corp (SYRA) stock is expected to climb by 2050, reaching an average of $58.46, a $34,291% jump from its current level. However, a wide range of estimates exists, with high and low targets of $61.72 and $58.51, respectively, highlighting the market's uncertainty.
Syra Health Corp Stock (SYRA) Year by Year Forecast
Syra Health Corp Stock (SYRA) Price Forecast for 2026
The predicted value for Syra Health Corp (SYRA) in 2026 is set at an average of $3.3504. Estimates vary from a peak of $5.6009 to a trough of $1.10, indicating an +1,871% surge from the present price of $0.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $1.1492 | $1.10 | $0.9792 | +575.98% |
| May, 2026 | $1.4247 | $1.3184 | $1.222 | +738.09% |
| June, 2026 | $4.8316 | $1.1639 | $4.1316 | +2,742% |
| July, 2026 | $5.8809 | $5.0935 | $5.6009 | +3,359% |
| August, 2026 | $5.2383 | $5.3783 | $5.4029 | +2,981% |
| September, 2026 | $4.8576 | $4.8876 | $5.0802 | +2,757% |
| October, 2026 | $4.4051 | $4.5332 | $4.5895 | +2,491% |
| November, 2026 | $1.8725 | $3.7525 | $4.1569 | +1,001% |
| December, 2026 | $2.1119 | $2.16 | $2.3763 | +1,142% |
Syra Health Corp Stock (SYRA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Syra Health Corp (SYRA) is $5.525, with a high forecast of $9.1714 and a low forecast of $1.8786. This indicates an +3,150% increase from the last price of $0.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.2793 | $2.2456 | $2.1093 | +1,241% |
| February, 2027 | $1.9472 | $1.9967 | $2.0549 | +1,045% |
| March, 2027 | $7.5614 | $1.8786 | $7.0215 | +4,348% |
| April, 2027 | $7.1608 | $7.2308 | $7.3861 | +4,112% |
| May, 2027 | $6.6901 | $6.6901 | $6.7281 | +3,835% |
| June, 2027 | $5.9766 | $5.9917 | $6.2864 | +3,416% |
| July, 2027 | $5.246 | $5.436 | $5.6314 | +2,986% |
| August, 2027 | $3.9253 | $3.858 | $5.0133 | +2,209% |
| September, 2027 | $3.0619 | $3.2019 | $3.0726 | +1,701% |
| October, 2027 | $3.0612 | $3.0239 | $2.9966 | +1,701% |
| November, 2027 | $8.7474 | $2.5932 | $8.0474 | +5,046% |
| December, 2027 | $9.4514 | $8.9402 | $9.1714 | +5,460% |
Syra Health Corp Stock (SYRA) Price Forecast for 2028
In 2028, Syra Health Corp (SYRA) is projected to reach an average price of $7.1322, with a high projection of $10.96 and a low estimate of $3.3079. This indicates an +4,095% rise from the last price of $0.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.5325 | $8.6725 | $8.9042 | +4,919% |
| February, 2028 | $7.9137 | $7.9137 | $8.3053 | +4,555% |
| March, 2028 | $7.0776 | $7.2058 | $7.6115 | +4,063% |
| April, 2028 | $4.2688 | $6.1488 | $6.7604 | +2,411% |
| May, 2028 | $4.1628 | $4.28 | $4.6344 | +2,349% |
| June, 2028 | $4.0539 | $4.1039 | $3.9455 | +2,285% |
| July, 2028 | $3.4456 | $3.4951 | $3.7267 | +1,927% |
| August, 2028 | $11.27 | $3.3079 | $10.73 | +6,529% |
| September, 2028 | $10.59 | $10.66 | $10.96 | +6,131% |
| October, 2028 | $9.8461 | $9.8461 | $10.09 | +5,692% |
| November, 2028 | $8.7873 | $8.8024 | $9.3734 | +5,069% |
| December, 2028 | $7.7804 | $7.9704 | $8.3039 | +4,477% |
Syra Health Corp Stock (SYRA) Price Forecast for 2029
The 2029 price forecast for Syra Health Corp Stock (SYRA) is $8.3822 on average, with a high prediction of $12.74 and a low estimate of $4.0225. This represents an +4,831% increase from the previous price of $0.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.5617 | $6.0517 | $7.4787 | +3,172% |
| February, 2029 | $4.9747 | $5.1147 | $5.18 | +2,826% |
| March, 2029 | $4.6977 | $4.7295 | $4.7712 | +2,663% |
| April, 2029 | $12.66 | $4.0225 | $11.96 | +7,349% |
| May, 2029 | $13.02 | $12.79 | $12.74 | +7,560% |
| June, 2029 | $11.83 | $11.97 | $12.41 | +6,857% |
| July, 2029 | $10.93 | $10.93 | $11.53 | +6,330% |
| August, 2029 | $9.7502 | $9.8784 | $10.56 | +5,635% |
| September, 2029 | $6.6651 | $8.5451 | $9.3639 | +3,821% |
| October, 2029 | $6.2138 | $6.3999 | $6.8925 | +3,555% |
| November, 2029 | $5.8285 | $5.8785 | $5.9274 | +3,329% |
| December, 2029 | $4.9439 | $4.9934 | $5.4323 | +2,808% |
Syra Health Corp Stock (SYRA) Price Forecast for 2030
Syra Health Corp Stock (SYRA) is expected to reach an average price of $10.53 in 2030, with a high forecast of $16.33 and a low forecast of $4.7372. This signifies an +6,096% surge from the last price of $0.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $14.98 | $4.7372 | $14.44 | +8,711% |
| February, 2030 | $14.03 | $14.10 | $14.53 | +8,150% |
| March, 2030 | $13.00 | $13.00 | $13.45 | +7,548% |
| April, 2030 | $11.94 | $11.97 | $12.46 | +6,925% |
| May, 2030 | $10.31 | $10.50 | $11.52 | +5,968% |
| June, 2030 | $8.4416 | $8.5124 | $9.944 | +4,866% |
| July, 2030 | $6.8875 | $7.0275 | $7.4508 | +3,951% |
| August, 2030 | $6.3342 | $6.4085 | $6.6067 | +3,626% |
| September, 2030 | $16.58 | $5.4518 | $15.88 | +9,652% |
| October, 2030 | $16.59 | $16.62 | $16.33 | +9,660% |
| November, 2030 | $15.12 | $15.26 | $15.91 | +8,795% |
| December, 2030 | $13.95 | $13.95 | $14.76 | +8,106% |
0.28%
3.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):